Trump Administration Wants to Protect FDA Power Over Abortion Pill
What: DOJ seeks dismissal of red-state lawsuit—not to defend the pill, but to preserve federal authority.
Key Line: “‘They’re basically saying states don’t get to just challenge FDA policy because they want to.’”
New data shows women face more complications after heart procedures.
Estrogen’s role in the brain goes far beyond reproduction, NYT reports.
ADF targets birth control and IUD coverage in campaign to cut ties with ACOG.
A small increase in births among women in their 30s and 40s offsets younger declines.
Bladder-leak brand Poise proposes using pads for hormone testing in rural areas.
NPR adds more detail to WHI’s shutdown and the loss of 1990s-era women’s health data.
WBUR spotlights MAP volunteers mailing abortion meds to banned states.
The influential Women’s Health Initiative will shut down without federal support.
An editorial calls for moving beyond reproductive-only focus in women’s health.
Study finds no mass OBGYN flight from states with abortion bans—yet.
Florida experienced the biggest abortion drop nationwide after its ban took effect.
Women who start menopause before age 40 may face faster cognitive decline.
Right-leaning outlet calls out bad data used to attack abortion pills.
The Guardian reviews how “fetal personhood” laws could criminalize abortion patients.
Vox explores new science to delay menopause—and whether we should.
New data shows fertilizing 7–9 eggs is ideal for live births and minimizing excess embryos.
ADF targets birth control and IUD coverage in campaign to cut ties with ACOG.
Pulitzer-winning series exposes the deadly impact of abortion bans.
Women under 50 are 40% less likely than men to get early transfusions after trauma.
Systemic hormones may worsen incontinence; local therapy helps, study says.